Viral Kansara

Company: Clearside Biomedical, Inc.

Job title: Vice President of Preclinical Development

Seminars:

Suprachoroidal Delivery for dry AMD: Targeted Suprachoroidal Access for Safer, More Precise Chorio-Retinal Drug Administration 3:00 pm

Comparing suprachoroidal delivery to conventional intravitreal injections: advantages in localizing therapy closer to disease sites with potentially improved safety profiles Exploring how suprachoroidal administration may limit anterior segment exposure and systemic circulation, reducing off-target effects Evaluating the potential to combine suprachoroidal delivery with gene therapy, small molecules, and sustained-release formulations to enhance efficacyRead more

day: Day1